$NSPR News

InspireMD, Inc. (NSPR) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript

InspireMD to Participate in Upcoming Bank of America Securities 2026 Global Healthcare Conference

Piper Sandler Reiterates Overweight on InspireMD, Lowers Price Target to $3

InspireMD, Inc. Q1 2026 Earnings Call Summary

InspireMD (NSPR) Q4 2025 Earnings Transcript

InspireMD (NSPR) Q2 2025 Earnings Transcript

InspireMD (NASDAQ:NSPR) Q1 Beat Fails to Impress as Stock Slides

InspireMD Reports First Quarter 2026 Financial Results

InspireMD, Inc. (NSPR) Q1 2026 Earnings Call Transcript

Transcript: InspireMD Q1 2026 Earnings Conference Call

InspireMD Q1 EPS $(0.16) Beats $(0.19) Estimate, Sales $3.398M Beat $2.698M Estimate

InspireMD Announces FDA Approval of Investigational Device Exemption Application for CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System

InspireMD Initiates Voluntary U.S. Recall of CGuard® Prime 135 cm Carotid Stent Delivery System

InspireMD Withdraws Prior Full Year 2026 Revenue Guidance; Says Given The Impact Of The Temporary Discontinuation Of Commercial Activity In The U.S. Pending The Anticipated FDA Approval Of Its Original CGuard Stent Delivery System In Q3 2026

InspireMD Initiates Voluntary U.S. Recall Of CGuard Prime 135cm Carotid Stent Delivery System; Recall Follows Technical Performance Of CGuard Prime 135cm Not Meeting Expectations; Recall Does Not Include CGuard Stent Implant; FDA Approval Of CGuard Prime 80cm For TCAR Anticipated In 2H 2026; FDA Approval, U.S. Availability Of Original CGuard Delivery System Anticipated In Q3 2026; Implementing Design Improvements To CGuard Prime Stent Delivery System

InspireMD Initiates Voluntary Recall For Its CGuard Prime 135 Cm Carotid Stent Delivery System

InspireMD Says FDA Approves IDE Application To Initiate CGUARDIANS III Pivotal Study Of SwitchGuard NPS, Including Next Gen Enhancements From Prior IDE Approval For Use With CGuard Prime 80 cm Stent Platform, In TCAR Procedures

InspireMD to Announce First Quarter 2026 Financial Results

After Plunging 15.2% in 4 Weeks, Here's Why the Trend Might Reverse for InspireMD (NSPR)

InspireMD to Participate in Upcoming 25th Annual Needham Virtual Healthcare Conference